Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

An expression vector was modified to permit the rapid synthesis of purified, 32P-labeled, glutathione S-transferase (GST)-retinoblastoma (RB) fusion proteins. The products were used to screen lambda gt11 expression libraries, from which we cloned a cDNA encoding a polypeptide (RBAP-1) capable of binding directly to a putative functional domain (the pocket) of the retinoblastoma gene product (RB). The RB "pocket" is known to bind, directly or indirectly, to the cellular transcription factor, E2F, implicated in cell growth control. We have found that RBAP-1 copurifies with E2F, interacts specifically with the adenovirus E4 ORF 6/7 protein, binds specifically and directly to a known E2F DNA recognition sequence, and contains a functional tranasactivation domain. Therefore, RBAP-1 is a species of E2F and can bind specifically to the RB pocket.

[1]  H. Kung,et al.  [43] Phosphorylation of Human Immune Interferon (IFN-γ) , 1986 .

[2]  S. Pestka,et al.  Characterization of receptors for immune interferon in U937 cells with 32P-labeled human recombinant immune interferon. , 1985, The Journal of biological chemistry.

[3]  F. Kaye,et al.  A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[4]  W. McClain,et al.  Rapid site-specific mutagenesis in plasmids. , 1987, Gene.

[5]  E. Y. Lee,et al.  A cellular protein that competes with SV40 T antigen for binding to the retinoblastoma gene product , 1991, Nature.

[6]  M. Ewen,et al.  The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner , 1992, Cell.

[7]  F. Graham,et al.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5. , 1977, The Journal of general virology.

[8]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[9]  D. Livingston,et al.  The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T , 1990, Cell.

[10]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[11]  E. Harlow,et al.  Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides , 1991, Molecular and cellular biology.

[12]  R. Weinmann,et al.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F , 1991, Cell.

[13]  A. Rustgi,et al.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product , 1991, Nature.

[14]  N. L. Thangue,et al.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor , 1991, Nature.

[15]  B. Franza,et al.  Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products , 1985, Journal of virology.

[16]  J. Nevins,et al.  Role of E2F transcription factor in E1A-mediated trans activation of cellular genes , 1991, Journal of virology.

[17]  J. Nevins,et al.  Activation of a preexisting cellular factor as a basis for adenovirus E1A-mediated transcription control. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[19]  J. Nevins,et al.  Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Nevins,et al.  Promoter interaction of the E1A‐inducible factor E2F and its potential role in the formation of a multi‐component complex. , 1987, The EMBO journal.

[21]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[22]  K. Münger,et al.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Piwnica-Worms,et al.  cdc2 gene expression at the G1 to S transition in human T lymphocytes. , 1990, Science.

[24]  R. Weinberg,et al.  Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Lee,et al.  Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. , 1990, Science.

[26]  Michael Carey,et al.  How different eukaryotic transcriptional activators can cooperate promiscuously , 1990, Nature.

[27]  P. Farnham,et al.  The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter , 1992, Molecular and cellular biology.

[28]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[29]  Joseph R. Nevins,et al.  The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.

[30]  Pearl S Huang,et al.  Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product , 1991, Nature.

[31]  J. Nevins,et al.  A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. , 1990, The EMBO journal.

[32]  J. Lindsay,et al.  Hydroxyurea reversal of inhibition and use as a cell-synchronizing agent. , 1967, The Journal of biological chemistry.

[33]  J. Nevins,et al.  A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex , 1992, Cell.

[34]  M. Marton,et al.  The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA , 1990, Journal of virology.

[35]  W. Lee,et al.  Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[36]  Marc Vidal,et al.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F , 1992, Cell.

[37]  P. Hearing,et al.  The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex. , 1989, Genes & development.

[38]  Y. Qian,et al.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.

[39]  J. Nevins,et al.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding , 1989, Molecular and cellular biology.

[40]  J. Nevins,et al.  Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Perricaudet,et al.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells , 1987, Journal of virology.

[42]  J. Nevins,et al.  The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. , 1992, Genes & development.

[43]  K. Takada,et al.  Synchronous and sequential activation of latently infected Epstein-Barr virus genomes , 1989, Journal of virology.

[44]  H. Singh,et al.  Molecular cloning of sequence-specific DNA binding proteins using recognition site probes. , 1989, BioTechniques.

[45]  R. Weinberg,et al.  Point mutational inactivation of the retinoblastoma antioncogene. , 1989, Science.

[46]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[47]  M. Ewen,et al.  Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product , 1990, Molecular and cellular biology.

[48]  N. Dyson,et al.  The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. , 1990, The EMBO journal.

[49]  L. Tsai,et al.  Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F , 1992, Nature.

[50]  J. Nevins,et al.  Genetic analysis of the adenovirus E4 6/7 trans activator: interaction with E2F and induction of a stable DNA-protein complex are critical for activity , 1991, Journal of virology.

[51]  W. Lee,et al.  Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. , 1990, The EMBO journal.

[52]  T. L. McGee,et al.  Structure and partial genomic sequence of the human retinoblastoma susceptibility gene. , 1989, Gene.

[53]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[54]  A. Ricksten,et al.  The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells. , 1988, Nucleic acids research.

[55]  V. Garsky,et al.  Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. , 1990, The Journal of biological chemistry.

[56]  W. Lee,et al.  C-terminal truncation of the retinoblastoma gene product leads to functional inactivation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[57]  W. Kaelin,et al.  Identification of a growth suppression domain within the retinoblastoma gene product. , 1992, Genes & development.

[58]  F. Kaye,et al.  Identification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene product , 1991, Cell.

[59]  E. Paucha,et al.  Identification of a region of simian virus 40 large T antigen required for cell transformation , 1990, Journal of virology.

[60]  E. Flemington,et al.  Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain , 1992, Journal of virology.

[61]  Chun-Ming Huang,et al.  SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family , 1989, Cell.

[62]  J. Azizkhan,et al.  Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo , 1989, Molecular and cellular biology.

[63]  David M. Livingston,et al.  The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.

[64]  W. Rutter,et al.  Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos. , 1992, Science.

[65]  D. Livingston,et al.  The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[66]  W. Kaelin,et al.  The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein , 1991, Cell.

[67]  J. Nevins,et al.  An adenovirus E4 gene product trans-activates E2 transcription and stimulates stable E2F binding through a direct association with E2F. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Michael Primig,et al.  Anatomy of a transcription factor important for the Start of the cell cycle in Saccharomyces cerevisiae , 1992, Nature.

[69]  D. Livingston,et al.  Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Pim,et al.  Monoclonal antibodies specific for simian virus 40 tumor antigens , 1981, Journal of virology.

[71]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.